We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+8.72%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$58.1M
AUM Growth
-$17.9M
Cap. Flow
-$4.42M
Cap. Flow %
-7.61%
Top 10 Hldgs %
43.93%
Holding
340
New
63
Increased
59
Reduced
56
Closed
151

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$2.31M
2
AMGN icon
Amgen
AMGN
+$1.97M
3
IBB icon
iShares Biotechnology ETF
IBB
+$1.79M
4
TSRO
TESARO, Inc.
TSRO
+$1.56M
5
CLX icon
Clorox
CLX
+$1.3M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$5.02M
2
AKBA icon
Akebia Therapeutics
AKBA
+$3.63M
3
FL
Foot Locker
FL
+$2.12M
4
GIS icon
General Mills
GIS
+$2.03M
5
LULU icon
lululemon athletica
LULU
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 37.51%
2 Consumer Staples 17.11%
3 Consumer Discretionary 2.69%
4 Communication Services 1.36%
5 Materials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CALM icon
201
PUT
Cal-Maine
CALM
$4.2B
– –
-3,800
Closed -$8K
CCEP icon
202
Coca-Cola Europacific Partners
CCEP
$46.5B
– –
-10,729
Closed -$425K
CHD icon
203
CALL
Church & Dwight Co
CHD
$23.2B
– –
-40,900
Closed -$49K
CLDX icon
204
CALL
Celldex Therapeutics
CLDX
$2.77B
– –
-2,247
Closed -$9K
CRBP icon
205
CALL
Corbus Pharmaceuticals
CRBP
$167M
– –
-420
Closed -$4K
CRBP icon
206
PUT
Corbus Pharmaceuticals
CRBP
$167M
– –
-887
Closed -$20K
CSCO icon
207
CALL
Cisco
CSCO
$441B
– –
-20,000
Closed -$1K
CTSH icon
208
Cognizant
CTSH
$21.2B
– –
-4,600
Closed -$274K
CTSH icon
209
PUT
Cognizant
CTSH
$21.2B
– –
-4,600
Closed -$2K
DIS icon
210
CALL
Walt Disney
DIS
$170B
– –
-12,500
Closed -$17K
DPZ icon
211
CALL
Domino's
DPZ
$10.7B
– –
-5,000
Closed -$13K
DPZ icon
212
Domino's
DPZ
$10.7B
– –
-6,304
Closed -$1.16M
DPZ icon
213
PUT
Domino's
DPZ
$10.7B
– –
-32,200
Closed -$43K
ESPR
214
CALL
DELISTED
Esperion Therapeutics
ESPR
– –
-24,100
Closed -$16K
ESPR
215
DELISTED
Esperion Therapeutics
ESPR
– –
-22,834
Closed -$840K
EXEL icon
216
CALL
Exelixis
EXEL
$14.1B
– –
-20,000
Closed -$87K
EXP icon
217
CALL
Eagle Materials
EXP
$6.36B
– –
-22,300
Closed -$14K
EXP icon
218
PUT
Eagle Materials
EXP
$6.36B
– –
-4,100
Closed -$16K
FL
219
DELISTED
Foot Locker
FL
– –
-28,300
Closed -$2.12M
FL
220
PUT
DELISTED
Foot Locker
FL
– –
-28,300
Closed -$42K
GDX icon
221
CALL
VanEck Gold Miners ETF
GDX
$21.8B
– –
-10,000
Closed -$8K
GDX icon
222
PUT
VanEck Gold Miners ETF
GDX
$21.8B
– –
-10,000
Closed -$3K
B
223
CALL
Barrick Mining
B
$58.5B
– –
-13,700
Closed -$4K
B
224
Barrick Mining
B
$58.5B
– –
-13,510
Closed -$257K
B
225
PUT
Barrick Mining
B
$58.5B
– –
-33,500
Closed -$24K
7 8
9
10 11

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q2 2017 Portfolio in Review

As of Q2 2017, FT Options held 340 positions worth $58.1M, down 24% from $76M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

FT Options withdrew a net $4.42M in Q2 2017, closing 151 positions and reducing 56 holdings. Its most notable exit was Foot Locker, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, FT Options opened a new position in Amgen worth $2.08M.

  • FT Options's largest Q2 2017 buy was Amgen: 12,082 shares worth $2.08M.
  • FT Options added most to Clovis Oncology, Inc. in Q2 2017, an estimated $2.31M increase.
  • FT Options's biggest Q2 2017 reduction was Abbott, cutting an estimated $5.02M.
  • FT Options fully exited Foot Locker in Q2 2017, selling an estimated $2.12M.
  • FT Options's ten largest holdings make up 44% of its $58.1M portfolio in Q2 2017.
  • FT Options opened 63 new positions and closed 151 in Q2 2017.
  • FT Options's portfolio value fell 24% quarter-over-quarter to $58.1M.

Based on FT Options's 13F filing for Q2 2017, filed 11 Aug 2017.